Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Regulation of EP4 expression via the Sp-1 transcription factor: inhibition of expression by anti-cancer agents.

Kambe A, Iguchi G, Moon Y, Kamitani H, Watanabe T, Eling TE.

Biochim Biophys Acta. 2008 Jun;1783(6):1211-9. doi: 10.1016/j.bbamcr.2008.01.032. Epub 2008 Feb 20.

2.

The cyclooxygenase inhibitor sulindac sulfide inhibits EP4 expression and suppresses the growth of glioblastoma cells.

Kambe A, Yoshioka H, Kamitani H, Watanabe T, Baek SJ, Eling TE.

Cancer Prev Res (Phila). 2009 Dec;2(12):1088-99. doi: 10.1158/1940-6207.CAPR-09-0140. Epub 2009 Nov 24.

3.
4.

Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.

Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE.

J Biol Chem. 2004 Feb 20;279(8):6883-92. Epub 2003 Dec 8.

6.

Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.

Chun JY, Hu Y, Pinder E, Wu J, Li F, Gao AC.

Mol Cancer Ther. 2007 Sep;6(9):2572-80.

7.

Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells.

Chen Y, Tang Q, Wu J, Zheng F, Yang L, Hann SS.

J Exp Clin Cancer Res. 2015 Dec 21;34:154. doi: 10.1186/s13046-015-0272-0.

9.

Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.

Sharma SD, Meeran SM, Katiyar SK.

Mol Cancer Ther. 2010 Mar;9(3):569-80. doi: 10.1158/1535-7163.MCT-09-0638. Epub 2010 Feb 9. Erratum in: Mol Cancer Ther. 2012 Sep;11(9):2072-3.

10.

Expression and regulation of the rat prostaglandin E2 receptor type 4 (EP4) in pregnant cervical tissue.

Chien EK, Macgregor C.

Am J Obstet Gynecol. 2003 Nov;189(5):1501-10.

PMID:
14634592
12.
13.

Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.

Zheng Y, Ritzenthaler JD, Sun X, Roman J, Han S.

Cancer Res. 2009 Feb 1;69(3):896-904. doi: 10.1158/0008-5472.CAN-08-2677. Epub 2009 Jan 27.

14.

Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome.

Kim JI, Lakshmikanthan V, Frilot N, Daaka Y.

Mol Cancer Res. 2010 Apr;8(4):569-77. doi: 10.1158/1541-7786.MCR-09-0511. Epub 2010 Mar 30.

15.

Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.

Oshima H, Popivanova BK, Oguma K, Kong D, Ishikawa TO, Oshima M.

Cancer Sci. 2011 Apr;102(4):713-9. doi: 10.1111/j.1349-7006.2011.01847.x. Epub 2011 Feb 2.

16.

Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.

Oh JM, Kim SH, Lee YI, Seo M, Kim SY, Song YS, Kim WH, Juhnn YS.

Carcinogenesis. 2009 Jan;30(1):141-9. doi: 10.1093/carcin/bgn236. Epub 2008 Oct 9.

PMID:
18849297
18.

Indomethacin decreases EP2 prostanoid receptor expression in colon cancer cells.

Fujino H, Chen XB, Regan JW, Murayama T.

Biochem Biophys Res Commun. 2007 Aug 3;359(3):568-73. Epub 2007 May 30.

19.

The induction of S100p expression by the Prostaglandin E₂ (PGE₂)/EP4 receptor signaling pathway in colon cancer cells.

Chandramouli A, Mercado-Pimentel ME, Hutchinson A, Gibadulinová A, Olson ER, Dickinson S, Shañas R, Davenport J, Owens J, Bhattacharyya AK, Regan JW, Pastorekova S, Arumugam T, Logsdon CD, Nelson MA.

Cancer Biol Ther. 2010 Nov 15;10(10):1056-66. doi: 10.4161/cbt.10.10.13373. Epub 2010 Nov 15.

Supplemental Content

Support Center